Sarcopenia and cachexia: molecular mechanisms and therapeutic interventions
Abstract Sarcopenia is defined as a muscle‐wasting syndrome that occurs with accelerated aging, while cachexia is a severe wasting syndrome associated with conditions such as cancer and immunodeficiency disorders, which cannot be fully addressed through conventional nutritional supplementation. Sarc...
Saved in:
Main Authors: | Tiantian Wang, Dong Zhou, Zhen Hong |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | MedComm |
Subjects: | |
Online Access: | https://doi.org/10.1002/mco2.70030 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sarcopenia as a leading component of malignant cachexia syndrome
by: V. K. Lyadov, et al.
Published: (2012-02-01) -
The prevalence and prognostic significance of Sarcopenia and Adipopenia in Pleural Mesothelioma
by: Andrew C. Kidd, et al.
Published: (2024-01-01) -
Associations of cachexia and frailty with amyotrophic lateral sclerosis
by: Tracy L. Peters, et al.
Published: (2025-02-01) -
Comparative Study on Associations Between Lung Cancer Prognosis and Diagnostic Criteria Set by the European Palliative Care Research Collaboration and the Asian Working Group for Cachexia
by: Utae Katsushima, et al.
Published: (2025-01-01) -
Lipid peroxidation and sarcopenia: molecular mechanisms and potential therapeutic approaches
by: Yifan Lu, et al.
Published: (2025-02-01)